There Are no reviews yet.

Availability:In Stock
Category:
Description

This image features PACICOT-250, a Paediatric Oral Suspension containing Paracetamol IP. Based on the branding and the image provided, here is a breakdown of the product and how we can promote it for Accott Healthcare.


Product Overview: PACICOT-250

  • Active Ingredient: Paracetamol (250mg per 5ml).

  • Form: Oral Suspension (Liquid).

  • Target Audience: Infants and children.

  • Primary Uses: * Relieving mild to moderate pain (teething, headaches, sore throats).

    • Reducing high temperature (fever), including post-immunization pyrexia.


Marketing Strategy Ideas

1. Social Media Copy (Instagram/Facebook)

Headline: Gentle Care for Little Smiles. πŸ‘Άβœ¨ Body: When fever or pain interrupts your child’s play, trust PACICOT-250. Our advanced Paracetamol Paediatric Oral Suspension is designed for fast-acting relief and accurate dosing, ensuring your little one gets back to being themselves in no time.

  • βœ… Trusted Formula

  • βœ… Effective Fever Control

  • βœ… Child-Friendly Taste Call to Action: Contact your nearest distributor or visit www.accotthealthcare.com for more details. #AccottHealthcare #Pacicot250 #ChildCare #FeverRelief #ParentingHacks

2. Promotional Banner Elements

If you want to design a new banner for this specific product, I suggest using these key highlights:

  • Visual: Keep the soft, teal-and-white theme from the packaging to maintain brand recognition.

  • Key Text: “Fast Relief from Fever & Pain.”

  • Footer: Include your contact number 8708518695 and the “Shop Now” button leading to the website.

3. USP (Unique Selling Points) for Sales Reps

  • Concentrated Strength: The 250mg strength is ideal for older children who require a higher dose than the standard 120mg/5ml infant drops, meaning less liquid for the child to swallow.

  • Quality Standard: Complies with IP (Indian Pharmacopoeia) standards for safety and efficacy.

Reviews (0)

There are no reviews yet.

Be the first to review “PACICOT-250 Oral Suspension”

Your email address will not be published. Required fields are marked *